糖尿病新世界
糖尿病新世界
당뇨병신세계
DIABETES NEW WORLD
2015年
6期
30-31
,共2页
津力达颗粒%亚莫利%2型糖尿病%临床疗效
津力達顆粒%亞莫利%2型糖尿病%臨床療效
진력체과립%아막리%2형당뇨병%림상료효
Jinlida particles%Glimepiride%Type 2 diabetes%Clinical effect
目的:探讨津力达颗粒联合亚莫利治疗2型糖尿病的临床疗效。方法选取该院2012年12月-2013年12月中收治的被确诊为2型糖尿病患者100例,按照随机分配原则分为治疗组和对照组,每组患者为50例,治疗组患者主要采用津力达颗粒联合亚莫利进行治疗,而对照组患者只采用亚莫利进行治疗,对比两组患者的临床疗效。结果所有患者经过治疗后,治疗组患者总有效率达到了94%,而对照组只有76%,相比差异显著(P<0.05);两组患者经治疗后,空腹血糖(FPG)、餐后2 h血糖(2 hPG)以及糖化血红蛋白(HbA1c)相比于之前显著降低;而治疗组的血糖达标时间、低血糖发生率显著好于对照组患者,差异有统计学意义(P<0.05)。结论对于2型糖尿病患者采用津力达颗粒联合亚莫利治疗,临床效果显著,值得在临床上进行推广应用。
目的:探討津力達顆粒聯閤亞莫利治療2型糖尿病的臨床療效。方法選取該院2012年12月-2013年12月中收治的被確診為2型糖尿病患者100例,按照隨機分配原則分為治療組和對照組,每組患者為50例,治療組患者主要採用津力達顆粒聯閤亞莫利進行治療,而對照組患者隻採用亞莫利進行治療,對比兩組患者的臨床療效。結果所有患者經過治療後,治療組患者總有效率達到瞭94%,而對照組隻有76%,相比差異顯著(P<0.05);兩組患者經治療後,空腹血糖(FPG)、餐後2 h血糖(2 hPG)以及糖化血紅蛋白(HbA1c)相比于之前顯著降低;而治療組的血糖達標時間、低血糖髮生率顯著好于對照組患者,差異有統計學意義(P<0.05)。結論對于2型糖尿病患者採用津力達顆粒聯閤亞莫利治療,臨床效果顯著,值得在臨床上進行推廣應用。
목적:탐토진력체과립연합아막리치료2형당뇨병적림상료효。방법선취해원2012년12월-2013년12월중수치적피학진위2형당뇨병환자100례,안조수궤분배원칙분위치료조화대조조,매조환자위50례,치료조환자주요채용진력체과립연합아막리진행치료,이대조조환자지채용아막리진행치료,대비량조환자적림상료효。결과소유환자경과치료후,치료조환자총유효솔체도료94%,이대조조지유76%,상비차이현저(P<0.05);량조환자경치료후,공복혈당(FPG)、찬후2 h혈당(2 hPG)이급당화혈홍단백(HbA1c)상비우지전현저강저;이치료조적혈당체표시간、저혈당발생솔현저호우대조조환자,차이유통계학의의(P<0.05)。결론대우2형당뇨병환자채용진력체과립연합아막리치료,림상효과현저,치득재림상상진행추엄응용。
Objective To investigate the clinical effect of combined Amaryl Jinlida particles in treatment of type 2 diabetes melli-tus. Methods In our hospital 2012 December to 2013 12 months were diagnosed in 100 patients with type 2 diabetes, according to a randomized divided into treatment group and control group, each group of patients for 50 cases, the patients in the treatment group were mainly adopts Jinlida particles combined with Amaryl treatment, while patients in the control group only used the Amoli treatment, the clinical effects were compared between the two groups patients. Results All the patients after treatment, the patients in the treatment group the total effective rate was 94%, and only 76%in the control group, significant difference (P<0.05);the patients in the two groups after treatment, fasting blood glucose (FPG), 2 hour postprandial blood glucose (2hPG) and glycosy-lated hemoglobin (HbA1c) compared to before the decreased significantly;the glucose standard time, the incidence of hypoglycemi-a in treatment group was significantly better than the control group of patients, with significant difference (P<0.05). Conclusion The combined treatment using Amaryl Jinlida particles in patients with type 2 diabetes, a significant clinical effect, worth in clini-cal application.